Skip to main content
OpenTrials

Clinical trial condition

Genital Neoplasms, Female

Explore clinical trials studying Genital Neoplasms, Female. Study availability and eligibility vary by location and protocol.

4,586 public trials 1,038 recruiting studies
Refine in advanced search Browse all conditions

Genital Neoplasms, Female trial results

Recruiting

A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors

NCT06533332

Conditions
Adnexal Diseases, Advanced Solid Tumor, Breast Diseases, +31 more
Locations
  • Macquarie University Health Ryde, New South Wales, Australia
  • The Kinghorn Cancer Center Sydney, New South Wales, Australia
  • Westmead Hospital Westmead, New South Wales, Australia
  • Cancer Research SA Adelaide, South Australia, Australia
View Trial Details
Recruiting

Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer

NCT06930755

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • OSF Saint Francis Medical Center Peoria, Illinois, United States
  • Washington University School of Medicine in St. Louis St Louis, Missouri, United States
  • Penn Medicine - Perelman Center for Advanced Medicine Philadelphia, Pennsylvania, United States
  • Tennessee Oncology Nashville, Tennessee, United States
View Trial Details
Recruiting

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

NCT06303505

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +22 more
Locations
  • The University of Alabama Birmingham, Alabama, United States
  • Mount Sinai New York, United States
  • Christ Hospital Cincinnati, Ohio, United States
  • Ohio State University Columbus, Ohio, United States
View all 15 locations
View Trial Details
Recruiting

A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine

NCT06682988

Conditions
Adnexal Diseases, Advanced High-Grade Epithelial Ovarian Cancer, Fallopian Tube Cancers, +12 more
Locations
  • First Physicians Group /ID# 272180 Sarasota, Florida, United States
  • St. Elizabeth Medical Center - Edgewood /ID# 272113 Edgewood, Kentucky, United States
  • Baptist Health Lexington /ID# 272211 Lexington, Kentucky, United States
  • UMass Memorial Medical Center - Belmont Street /ID# 272122 Worcester, Massachusetts, United States
View all 52 locations
View Trial Details

Related conditions